Loading clinical trials...
Loading clinical trials...
Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma
Conditions
Interventions
filgrastim
rituximab
+6 more
Locations
174
Germany
Haematologisch Onkologische Praxis
Aachen, Germany
Klinikum St. Marien
Amberg, Germany
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie
Ansbach, Germany
II. Medizinische Klinik
Aschaffenburg, Germany
Specialist Practice for Oncology
Aschaffenburg, Germany
Haematologische Praxis
Augsburg, Germany
Start Date
January 1, 2001
Primary Completion Date
August 5, 2010
Completion Date
August 5, 2010
Last Updated
May 18, 2021
NCT05529069
NCT05139017
NCT06337318
NCT06263491
NCT07388563
NCT07350863
Lead Sponsor
German High-Grade Non-Hodgkin's Lymphoma Study Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions